Kari Krogstad - Medistim ASA CEO Pres

All Insiders . Norway . 
Stock . Medistim ASA . Stakeholders . Insider . Kari Krogstad
MEDI Stock  NOK 148.00  7.00  4.96%   

Insider

Kari Krogstad is CEO Pres of Medistim ASA
Age 59
Phone47 23 05 96 60
Webhttps://www.medistim.com

Medistim ASA Management Efficiency

The company has return on total asset (ROA) of 0.1953 % which means that it generated a profit of $0.1953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3112 %, meaning that it generated $0.3112 on every $100 dollars invested by stockholders. Medistim ASA's management efficiency ratios could be used to measure how well Medistim ASA manages its routine affairs as well as how well it operates its assets and liabilities.
Medistim ASA has accumulated 17.08 M in total debt with debt to equity ratio (D/E) of 3.4, implying the company greatly relies on financing operations through barrowing. Medistim ASA has a current ratio of 3.61, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medistim ASA until it has trouble settling it off, either with new capital or with free cash flow. So, Medistim ASA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medistim ASA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medistim to invest in growth at high rates of return. When we think about Medistim ASA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Anders NeijberPhotocure
N/A
Ingunn EttestolArendals Fossekompani ASA
50
Per SrlieBorregaard ASA
66
Stefan HanssonMutasKitron ASA
57
Hanne WattsArendals Fossekompani ASA
N/A
Kristin MisundBorregaard ASA
58
Anny enAF Gruppen ASA
N/A
Patricia KellyPhotocure
N/A
Mindaugas SestokasKitron ASA
52
Tormod SolbergAF Gruppen ASA
52
Per LyngstadBorregaard ASA
62
Tuva BarnholtBorregaard ASA
61
Hans ThomassenKitron ASA
58
Pl RombergBorregaard ASA
N/A
KariAnne SlaaenArendals Fossekompani ASA
N/A
Knut EkernAF Gruppen ASA
50
David MoskowitzPhotocure
N/A
Kelly CPCUAF Gruppen ASA
N/A
Carsten ChristensenKitron ASA
57
Kari MDPhotocure
N/A
Magnus LindsethKitron ASA
46
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. MEDISTIM ASA operates under Medical Equipment classification in Norway and is traded on Oslo Stock Exchange. It employs 105 people. Medistim ASA (MEDI) is traded on Oslo Stock Exchange in Norway and employs 116 people.

Management Performance

Return On Equity0.31
Return On Asset0.2

Medistim ASA Leadership Team

Elected by the shareholders, the Medistim ASA's board of directors comprises two types of representatives: Medistim ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medistim. The board's role is to monitor Medistim ASA's management team and ensure that shareholders' interests are well served. Medistim ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medistim ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Jakobsen, Chief Officer
Ole Robsrud, CEO AS
Hakon Grothe, Chief Officer
Roger Morberg, VP Sales
Kari Krogstad, CEO Pres
Helge Borslid, VP Manufacturing
Mike Farbelow, Pres Inc
Cindy Kaffai, Country GmbH
Hge Wetterhus, VP Marketing
Ole Eiksund, Chief Officer

Medistim Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medistim ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.31
Return On Asset0.2
Profit Margin0.21 %
Operating Margin0.27 %
Current Valuation4.12 B
Shares Outstanding18.26 M
Shares Owned By Insiders14.97 %
Shares Owned By Institutions73.95 %
Price To Earning36.32 X
Price To Book12.24 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Medistim Stock

Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY